FDA panel to evaluate Sirion’s Durezol
Executive Summary
FDA's Dermatologic Drugs Advisory Committee will meet May 29 to discuss Sirion Therapeutics' Durezol (difluprednate) for the treatment of inflammation and pain following ocular surgery. The NDA for the topical ophthalmic steroid has a June 26 action date...
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.